Clinical trial
A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants…
NCT01904279 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT01904279 |
|---|---|
| Title | A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA) |
| Official title | A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Polyarticular Juvenile Idiopathic Arthritis |
| Acronym | JIGSAW 117 |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Juvenile Idiopathic Arthritis |
| Intervention type | Drug |
| Interventions | Tocilizumab |
| Enrollment | 52 |
| Start date | Jul 1, 2013 |
| Primary completion | May 1, 2016 |
| Completion | May 1, 2016 |
| First posted | Jul 22, 2013 |
| Last update posted | Jun 14, 2017 |
| Countries | Argentina, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Russia, Spain, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: